By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Diagnostics Laboratories (Dx)2.76B78.08%
Biopharma Laboratory Services (BLS)780.6M22.07%
Intercompany eliminations and other-5.1M-0.14%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
U.S.11.65B83.50%
Europe1.26B9.00%
Other558.07M4.00%
North America487.88M3.50%